mechanisms for controlling the directed differentiation of dental MSCs. However, the regulation of the directed differentiation process of odontogenic MSCs, especially in dynamic differentiation stage, and their molecular mechanism remain unclear.
Histone modification is critical in controlling the proliferation, differentiation, migration and other functions of stem cells, especially in the differentiation of stem cells. 5, 6 One type of histone modification, methylation, occurs on the N-terminal of lysine and arginine residues, which results in transcriptional activation or inhibition. [7] [8] [9] [10] One methylation regulatory protein, lysine demethylase 1A (KDM1A), is a flavin-dependent monoamine oxidase in humans. 11 Previous studies have shown that KDM1A can specifically catalyse the demethylation of mono-and di-methyl histone H3 lysine 4 (H3K4me2/1) and mono-and di-methyl histone H3 lysine 9 (H3K9me2/1), which regulate the gene activation, proliferation, differentiation and migration of MSCs. [11] [12] [13] [14] [15] While, study has shown that H3K9me2 was significantly decreased when BMMSCs were differentiated with neuronal induction medium. 16 Others demonstrate that depletion of KDM1A promotes osteogenic differentiation and regulates osteogenesis-associated genes expression through its histone demethylase activity in human adipose-derived stem cells, and the expression of H3K4me2 was up-regulated in KDM1A knockdown cells. 17 These indicated that KDM1A might also have potential to regulate the directed differentiation in odontogenic MSCs.
In the present study, we sought to study the osteo/dentinogenic differentiation capacity of KDM1A using apical papilla stem cells (SCAPs). Our findings suggested that knocking down of KDM1A could reduce the early osteo/dentinogenic marker, ALP and mineralization in vitro, and enhance the osteo/dentinogenic differentiation markers and osteo/dentinogenesis in vivo in SCAPs. We also discovered that KDM1A and PLOD2 could form a protein complex in SCAPs, and KDM1A may regulate the osteo/dentinogenic differentiation by interacting with PLOD2.
| MATERIAL S AND ME THODS

| Primary cell culture
All human stem cell experiments followed the ISSCR "Guidelines for the Conduct of Human Embryonic Stem Cell Research". The teeth were obtained from the Beijing Stomatological Hospital, Capital Medical University, according to approved guidelines. First, the teeth were stored under sterile conditions and rinsed with phosphate-buffered saline (PBS). The tissue of the apical papilla was cut from the immature apical tissue, and the SCAPs were cultured according to previous methods. 18, 19 Subsequently, the separated tissues were placed in a solution of 4 mg/mL of dispase (Roche Diagnostics Corp., Indianapolis, IN, USA) and 3 mg/mL of collagenase type I (Worthington Biochemical Corp., Lakewood, NJ, USA)
for 1 h at 37°C. The single-cell suspensions were filtered using a 70-μm strainer (Falcon, BD Lab ware, Franklin Lakes, NJ, USA). SCAPs were cultured in alpha DMEM and 15% foetal bovine serum (FBS;
Invitrogen, Carlsbad, CA, USA), 2 mmol/L of glutamine, 100 μg/mL of streptomycin, and 100 U/mL of penicillin (Invitrogen) in an incubator under 5% CO 2 at 37°C. SCAPs at passages 3-5 were used in subsequent experiments. The human embryonic kidney 293T cells were purchased and cultured in complete DMEM medium with 10%
foetal bovine serum (FBS; Invitrogen), 100 μg/mL of streptomycin and 100 U/mL of penicillin (Invitrogen). The medium was changed every 3 days.
| Constructed plasmid and infected vial
According to standard methods, we constructed the plasmids and identified the structures by using restriction enzymes and sequence. The KDM1A-specific short hairpin RNAs (shRNA) were imported into the pLKO.1 lentiviral vector (Addgene, Cambridge, MA, USA 
| RNA isolation, real-time reverse transcriptasepolymerase chain reaction (real-time RT-PCR)
Total RNA was extracted from SCAPs using Trizol (Invitrogen, USA).
We amplified the target cDNA from 3-μg RNA according to the reverse transcriptase manufacturer's protocol (Invitrogen). Real-time RT-PCR was performed using the QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) and an IcycleriQ Multi-colour Real-time RT-PCR Detection System. The 2 −△△CT method was used to detect changes in gene expression. The primers for detecting specific genes are shown in Table S1 .
| Western blot analysis
SCAPs were lysed in RIPA buffer (10 mM of Tris-HCl, 1 mM of EDTA, 1% sodium dodecyl sulphate [SDS], 1% NP-40, 1:100 proteinase inhibitor cocktail, 50 mM of sodium fluoride and 50 mM of β-glycerophosphate).
After extraction, the protein samples were separated on a 4%-15% gradient SDS polyacrylamide gel (BioRad, Hercules, CA, USA) and transferred to polyvinylidene difluoride (PVDF) membranes using a semi-dry transfer apparatus (BioRad, Hercules, CA, USA). After blocking nonspecific binding to PVDF membranes in 5% skim milk for 1 hour, the PVDF membranes were washed 3 times with 1 × TBST. The membranes were incubated with the primary antibody overnight at 4°C. The immune complexes were reacted with horseradish peroxidase-conjugated 
| Alkaline Phosphatase (ALP) activity assay and Alizarin red detection
SCAPs were cultured in osteogenic-inducing medium, which contained 100 μM/mL of ascorbic acid, 2 mM of β-glycerophosphate, 
| Nude mouse transplantation
Our study was performed according to the animal experimentation ordinance of the Stomatological Hospital, Capital Medical University.
We used intact 8-week-old female nude (nu/nu) mice purchased 
| Immunohistochemical staining
| Protein mass spectrometry
The protein product was separate on a 4%-15% gradient SDS polyacrylamide gel (BioRad) and stained with Coomassie brilliant blue, then washed in glacial acetic acid (GAA) for 1 hour. The blue stained bands were cut from the polyacrylamide gel and their protein contents were subjected to protein mass spectrometry analysis (Q-Exactive, Thermo Scientific, USA).
| Statistical analyses
All statistical calculations were performed using SPSS version 22 statistical software. Student's t test was used to determine the statistical significance and a p ≤ .05 was considered significant.
| RE SULTS
| The regulatory function of KDM1A on the osteo/dentinogenic differentiation of SCAPs in vitro
To determine the function of KDM1A during the osteo/dentinogenic differentiation of SCAPs, we constructed a shRNA to ( Figure 1A,B) . We used osteogenic-inducing medium to culture the transduced SCAPs. After induction for 5 days, depletion of KDM1A was found to reduce the ALP activity, an early indicator for osteo/dentinogenic differentiation in SCAPs ( Figure 1C ). Accordingly, after induced for 2 weeks, the mineralization of KDM1Ash SCAPs was markedly decreased compared to Scramsh SCAPs, as detected by Alizarin red staining and quantitative calcium measurements ( Figure 1D ,E). However, Real-time RT-PCR analysis found that the osteogenic gene, BSP, was significantly increased at 1 week after induction, and the dentinogenic markers, DSPP and DMP1 were significantly increased at 1 and 2 weeks after induction in SCAP-KDM1Ash cells compared to the control group (Figure 2A-C) . Furthermore, the Real-time RT-PCR results also revealed that the mRNA levels of OSX, RUNX2 and DLX2
were significantly higher in KDM1Ash-SCAPs than the control group ( Figure 2D ). And Western blot results also showed that knock-down of KDM1A up-regulated the expression of DSPP and OSX in SCAPs ( Figure 2E ).
| Depletion of KDM1A enhanced the osteo/ dentinogenesis of SCAPs in vivo
To explore the function of KDM1A on the osteo/dentinogenesis of SCAPs in vivo, we transplanted SCAPs-Scramsh and SCAPs- groups ( Figure 3F-I) . Taken together, these results demonstrated that reduction of KDM1A expression increased the bone/dentin regeneration of SCAPs.
| The identification of the binding protein of KDM1A in SCAPs
Following transfection with a retroviral HA-KDM1A construct, we achieved SCAPs which overexpressed KDM1A, as confirmed by
Western blot ( Figure 4A ). We then used Co-IP assay and protein mass spectrometry to detect the possible binding partner of KDM1A
in SCAPs. The Coomassie Brilliant Blue staining results showed the presence of 3 significant different bands in KDM1A overexpressing
SCAPs compared with the vector group after Co-IP assay with HA antibody ( Figure 4B ). These blue stained bands were collected from the polyacrylamide gel and analysed by protein mass spectrometry.
The protein mass spectrometry results showed that there were 103 candidate ligand proteins of KDM1A in SCAPs, such as SYNCRIP, PLOD2, SND1, ASCC3 and IQGAP2 (Table S2 ). Based on the molecular size and peptide compatibility, we selected 1 potential binding protein, PLOD2, for further analysis. Indeed, the Co-IP assay results showed that PLOD2 could interact with KDM1A in SCAPs ( Figure 4C ).
| The regulatory function of PLOD2 on osteo/ dentinogenic differentiation of SCAPs in vitro
To confirm whether PLOD2 was involved in the regulation of osteo/ dentinogenic differentiation of KDM1A in SCAPs, we investigated were also highly increased in SCAP-PLOD2sh cells compared to the control group ( Figure 6D ).
| D ISCUSS I ON
The aim of tooth regeneration is to reconstruct the shape and function of teeth. SCAPs obtained from the apical papilla, which was found the capacity to differentiate into cells of the osteogenic, odontogenic, adipogenic and neurogenic lineages, is candidate seeding cell for tooth regeneration. 20 Understanding the mechanisms of the whole osteo/dentinogenic differentiation process of SCAPs is essential for regulation of SCAPs differentiation precisely and improving tooth regeneration. In MSC osteo/dentinogenic differentiation process, there are several stages, including initiating, early, middle, late and end stage. And there are several different markers that indicated the different stages of osteo/dentinogenic differentiation process.
RUNX2, OSX and DLX2 are considered the critical transcription factors for initiating osteo/dentinogenic differentiation in the osteo/ dentinogenic process, the expressions of RUNX2 and OSX could be induced by the DLX gene family, and RUNX2 can activate the expression of OSX, thus enhancing the osteo/dentinogenic differentiation. [21] [22] [23] The previous study reported that ALP is an early differentiation indicator of osteo/dentinogenic differentiation. 24 BSP is one of the important proteins expressed in the bone extracellular matrix, DSPP and DMP1 are classic odontogenic markers, DSPP is a key gene in the process of dentin formation in humans and mice, and DMP1 can effectively regulate the expression of DSPP, they are markers for middle and late stage of osteo/dentinogenic differentiation. [25] [26] [27] The mineralization phenotype is indicator for the end stage of osteo/dentinogenic differentiation process. Investigating these markers will be helpful to understand the dynamics in osteo/dentinogenic differentiation process.
Previous study reports that depletion of KDM1A promotes osteogenic differentiation and regulates osteogenesis-associated genes expression. 17 In present study, we found that knock-down the osteo/dentinogenesis in vivo, consistent with previous report.
In addition, we also determined that silenced KDM1A reduced ALP activity and mineralization. Based on these discoveries, we specu- inhibition will promote osteo/dentinogenesis in vivo.
KDM1A is important in gene transcriptional activation or repression by demethylating H3K4me1/2 and H3K9me1/2, respectively.
Inhibition of KDM1A impeded the neurogenesis of human foetal neural stem cells via demethylation of H3K4me2. 15 In other study, an isoform of KDM1A was discovered and found that knock-down of this KDM1A isoform compromised neuronal differentiation by mediated H3K9me2 demethylation in collaboration with SVIL. 28 These findings suggested that KDM1A acquires selective substrate specificities (H3K9 vs H3K4) via associating with specific partner to differentially control specific gene expression in directed differentiation.
We then investigated the regulatory mechanism of KDM1A in SCAPs. KDM1A has been found to form protein complexes with other proteins during cell proliferation and differentiation. [29] [30] [31] In the present study, we identified several candidate binding partners of KDM1A including PLOD2. Indeed, further study confirmed that KDM1A could bind with PLOD2 in SCAPs. Katsuhiro et al. found that the expression of PLOD2 in BMMSCs was almost the same as in fibroblasts, but was significantly increased (6 times) after osteoblast induction, indicating that PLOD2 may be an important gene in the osteogenic differentiation of BMMSCs. 32, 33 Another highthroughput assay found that the expression of PLOD2 in adipose tissue was significantly higher than that in the bone tissue, suggesting that PLOD2 may exert different roles in different tissues. 34 In the present study, we observed that knock-down of PLOD2 reduced the ALP activity and mineralization, but increased the expression of BSP, DSPP, DMP1, OSX, RUNX2 and DLX2. Interestingly, these results are consistent with the in vitro phenotype of SCAPs after knock-out of KDM1A, indicated that KDM1A might apply the function in osteo/dentinogenic differentiation process by binding with PLOD2.
In conclusion, we identified that depletion of KDM1A inhibited the early osteo/dentinogenic marker-ALP and end-stage markermineralization in vitro, and enhanced initiating transcription factors including RUNX2, OSX and DLX2, middle and late stage osteo/dentinogenic differentiation markers including BSP, DSPP and DMP1 in vitro and osteo/dentinogenesis in vivo in SCAPs.
KDM1A might apply its regulation in osteo/dentinogenic differentiation process by interaction with its binding partner, PLOD2.
Our studies provided the further understanding of regulation mechanisms for directed differentiation process in dental tissue
MSCs and provided the potential target for enhancing dental tissue regeneration.
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